痴呆症护理研究和心理社会因素
1FLENI, Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
这项研究详细介绍了阿根廷患有遗传性阿尔茨海默病的患者的临床和神经成像资料,揭示了记忆和执行功能障碍,以及大脑缩和粉样蛋白积累.
科学领域:
- 神经学 神经学
- 遗传学 是一个遗传学.
- 神经成像是一种神经成像.
背景情况:
- 遗传因素,包括APP,PSEN1和PSEN2中的突变,在阿尔茨海默病 (AD) 的发展中具有重要意义.
- 阿尔茨海默病的家族形式与这些特定的基因突变密切相关.
研究的目的:
- 描述阿根廷被诊断患有遗传性阿尔茨海默病的患者的临床,神经成像和神经认知概况.
- 在南美队伍中调查遗传AD的特定表现.
主要方法:
- 这是一项对26名阿根廷患者进行的横截面观察性研究,这些患者确诊患有AD遗传突变 (PSEN1,PSEN2,APP).
- 评估包括神经认知测试 (记忆,执行功能,注意力,语言),结构性MRI和PET成像 (粉样蛋白的PIB,代谢的FDG).
主要成果:
- 大多数 (80%) 患者携带PSEN1突变.
- 神经认知评估表明,记忆和执行功能的初级障碍.
- 核磁共振扫描显示显著的皮质缩 (海马体,体区域);PET显示粉样蛋白沉积升高和降低葡萄糖代谢.
结论:
- 这项研究为阿根廷患者遗传性阿尔茨海默病的临床和神经成像特征提供了关键的见解.
- 使用神经认知测试,MRI和PET的综合性评估方法可以帮助了解疾病进展并制定未来的策略.
更多相关视频
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
4.3K
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
14.1K
相关概念视频
Dementia
482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
482
Psychological and Sociocultural Causes of Schizophrenia
438
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
438
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Cognitive Development During Adulthood
740
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
740
Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K
